AKT1 and glioblastoma: These results are in line with recent findings [38]–[40] showing a decrease in lactate levels following treatment with various inhibitors of the PI3K/AKT/mTOR signaling pathway in vitro and in vivo using different tumor models including adult glioblastoma.